Science
Mechanism of Action
The active component, Melittin, primarily functions by disrupting lipid bilayer membranes through pore formation, which can lead to cell lysis. It modulates intracellular calcium levels by inhibiting calmodulin, contributing to cell toxicity and death. Melittin also suppresses innate immune signaling pathways, specifically targeting TLR2, TLR4, CD14, NEMO, and PDGFRβ, resulting in reduced activation of p38, ERK1/2, AKT, PLCγ1, and decreased NF-κB translocation, thereby diminishing inflammatory responses. On the skin, it has been observed to regulate skin thickness, enhance filaggrin production, and reduce inflammatory cytokines, as well as exhibit antibacterial and antifungal properties, including the inhibition of P. acnes-induced inflammation.
Research
Clinical Evidence
Medium confidenceN/A
Key findings
- 01 In vitro, Melittin (0.7-1.05 µM) induced apoptosis in various cancer cells (renal, prostatic, ovarian, breast, and leukemia).
- 02 Melittin concentrations as low as 1.85 ± 0.75 µg/mL induced growth inhibition in K562 leukemic cells in vitro.
- 03 A concentration of 4 µg/mL caused significant cell death in MDA-MB-231 cancer cells; however, concentrations below 2 µg/mL did not significantly impact cell survival.
- 04 In a mouse model of atopic dermatitis, unspecified concentrations mitigated ovalbumin-triggered skin symptoms, regulating skin thickness, increasing filaggrin levels, and reducing inflammatory cytokines.
- 05 In a mouse model of *Streptococcus pyogenes* skin infection, unspecified concentrations reduced inflammatory reactions and improved lesions.
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Melittin's conformation shifts from random to alpha-helical at elevated pH values, with transitions noted around pK values of 6.8, 7.2, and 9.6 depending on concentration, indicating pH-sensitive activity. Storage at room temperature or freezer temperatures did not affect melittin content in honey bee venom over a six-month period.
Safety
Safety Profile
Specific safety data for METHIONYL S-MELITTIN SP is unavailable; assessments are based on Melittin, a major component of bee venom. Melittin is a recognized biotoxin and a significant pain-inducing substance, exerting strong surface effects on cell membranes. It causes pore formation in epithelial cells and destruction of red blood cells, demonstrating non-specific cytotoxicity, degradation, and hemolytic activity. The median hemolytic concentration (HC50) against human red blood cells is 16.28 ± 0.17 µg/mL, and the median lethal concentration (LC50) against immature human dendritic cells is 43.42 ± 0.86 µg/mL. Its inherent toxicity severely limits direct topical use, leading to research into strategies like nanomodification to reduce cytotoxicity and enhance specificity.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Despite intriguing preclinical data on anti-inflammatory and antimicrobial effects, the significant inherent toxicity, non-specific cytotoxicity, and high irritancy profile of Melittin, upon which METHIONYL S-MELITTIN SP is based, render it unsuitable for direct application in precision skincare formulations.
Related
Similar Ingredients
Finding similar ingredients…